Numab Company
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases such as chronic inflammation and cancer. It features a plug-and-play platform that substantially reduces the random nature of the discovery process to predictably yield ready-to-develop multispecific biotherapeutics.
Connections
Founded Date:
2011-01-01
Employee Number:
51-100
Headquarters:
Wadenswil, Zurich, Switzerland, Europe
Industry:
Drug Discovery & Development
Super Industry:
Biopharma & Life Science Tools
Phone Number:
41445330471
Investors:
BlackRock, Cormorant Asset Management, Mitsubishi UFJ Capital, Novo Holdings, RTW Investments
Ipo Status:
private
City:
Wädenswil
Region:
Zurich
Country:
Switzerland
Founders:
David Urech, Oliver Middendorp, Peter Lichtlen